Microfluidics is the science and engineering discipline that deals with controlling and manipulating volumes of liquids, typically in the microliter and nanoliter range, within channels typically ranging from micrometers to hundreds of micrometers in dimension. A single chip is capable of directing, blending, heating, and analyzing a sample via a network of etched or molded channels, reducing dependence on conventional laboratory infrastructure for specific analytical workflows. Reactions occur more rapidly due to the fluid’s confined space, leading to a significant decrease in reagent consumption. In many device types, microfluidic platforms enable decentralized and near-patient testing by reducing sample preparation steps, minimizing instrument complexity, and allowing faster analysis outside traditional laboratory environments. However, certain applications may still require trained personnel, specialized readers, quality control procedures, and regulatory validation before clinical deployment.
The market comprises the actual hardware constructed on this principle: the chips and cartridges containing the fluid network, and the supporting instrumentation such as pumps, valves, sensors, and controllers that enable fluid to flow through them and determine its outcome. This includes all the places where these systems are deployed – hospitals and clinical laboratories performing infectious diseases tests and cardiac screens, pharmaceutical and biotech companies performing drug screens on chips resembling organs, research institutions studying the behavior of individual cells, and forensics and environmental labs detecting contaminants and biological traces.
Based on the defined scope of microfluidic-enabled devices, components, and directly attributable platforms, the market is estimated at USD 26.9 billion in 2026 and is projected to reach USD 43 billion by 2031, growing at a CAGR of 9.8% over the 2026–2031 period.